Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance.

Cites (247)

Items 201–247 of 247

1. The Hidden Danger of Primary Fluconazole Prophylaxis for Patients with AIDS
   Johannes Berg, Cornelius Joseph Clancy, M. Hong Nguyen · 1998 · Clinical Infectious Diseases
2. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B
   Peter A. Warn · 2003 · Journal of Antimicrobial Chemotherapy
3. Possible Development of Resistance to Fluconazole During Suppressive Therapy for AIDS-Associated Cryptococcal Meningitis
   Arola Armengou, Carlos Porcar, José Manuel Mascaró, Fernando Garcia-Bragado · 1996 · Clinical Infectious Diseases
4. Teaching old drugs new tricks: reincarnating immunosuppressants as antifungal drugs.
   Jill R. Blankenship, William J. Steinbach, John R. Perfect, Joseph Heitman · 2003 · PubMed
5. In Vitro Interactions between Antifungals and Immunosuppressants against Aspergillus fumigatus Isolates from Transplant and Nontransplant Patients
   William J. Steinbach, Nina Singh, Jackie L. Miller, Daniel K. Benjamin, Wiley A. Schell, Joseph Heitman, John R. Perfect · 2004 · Antimicrobial Agents and Chemotherapy
6. Resistance to amphotericin B: emerging clinical and microbiological patterns
   Timothy R. Sterling, William G. Merz · 1998 · Drug Resistance Updates
7. Clinical efficacy of new antifungal agents
   Kauffman, Carol A · 2006 · Current Opinion in Microbiology
8. Attenuation of echinocandin activity at elevated concentrations: a review of the paradoxical effect
   Nathan P. Wiederhold · 2007 · Current Opinion in Infectious Diseases
9. Characterization of Heteroresistance to Fluconazole among Clinical Isolates of <i>Cryptococcus neoformans</i>
   Yamazumi, T., Pfaller, M. A., Messer, S. A., Houston, A. K., Boyken, L., Hollis, R. J., Furuta, I., Jones, R. N. · 2003 · Journal of Clinical Microbiology
10. Reduced susceptibility in laboratory-selected mutants of Aspergillus fumigatus to itraconazole due to decreased intracellular accumulation of the antifungal agent
    Elias K. Manavathu, José A. Vázquez, Pranatharthi Haran Chandrasekar · 1999 · International Journal of Antimicrobial Agents
11. Susceptibility of environmental versus clinical strains of pathogenic Aspergillus
    Ricardo Araújo, Cidália Pina‐Vaz, Acácio Gonçalves Rodrigues · 2006 · International Journal of Antimicrobial Agents
12. Antifungal drug susceptibility of Cryptococcus neoformans from clinical sources in Nairobi, Kenya
    Christine C. Bii, Koichi Makimura, Shigeru Abe, Haruhiko Taguchi, Olga M. Mugasia, Gunturu Revathi, Njeri Wamae, Shigeru Kamiya · 2006 · Mycoses
13. Cloning and characterization of CneMDR1: a Cryptococcus neoformans gene encoding a protein related to multidrug resistance proteins
    Susan J. Thornewell, Robert B. Peery, Paul L. Skatrud · 1997 · Gene
14. Fungicidal Synergism of Fluconazole and Cyclosporine in Candida albicans Is Not Dependent on Multidrug Efflux Transporters Encoded by the CDR1 , CDR2 , CaMDR1 , and FLU1 Genes
    Oscar Marchetti, Philippe Moreillon, Jose Manuel Entenza, Jacques Vouillamoz, Michel Pierre Glauser, Jacques Billé, Dominique Sanglard · 2003 · Antimicrobial Agents and Chemotherapy
15. Neurospora crassa FKS Protein Binds to the (1,3)?-Glucan Synthase Substrate, UDP-Glucose
    Rebecca Schimoler-O'Rourke, Samantha Renault, Wenjun Mo, Claude P. Selitrennikoff · 2003 · Current Microbiology
16. Transcriptional Regulation of MDR1 , Encoding a Drug Efflux Determinant, in Fluconazole-Resistant Candida albicans Strains through an Mcm1p Binding Site
    Perry J. Riggle, Carol A. Kumamoto · 2006 · Eukaryotic Cell
17. Regulation of azole drug susceptibility by Candida albicans protein kinase CK2
    Vincent M. Bruno, Aaron P. Mitchell · 2005 · Molecular Microbiology
18. Azole Drug Resistance as a Cause of Clinical Relapse in AIDS Patients with Cryptococcal Meningitis
    H Birley, Elizabeth M. Johnson, P McDonald, Christopher Martin Parry, P B Carey, David W. Warnock · 1995 · International Journal of STD & AIDS
19. Fluconazole Treatment Is Effective against a Candida albicans erg3/erg3 Mutant In Vivo Despite In Vitro Resistance
    Taiga Miyazaki, Yoshitsugu Miyazaki, Koichi Izumikawa, Hiroshi Kakeya, Shunichi Miyakoshi, John E. Bennett, Shigeru Kohno · 2006 · Antimicrobial Agents and Chemotherapy
20. Emerging echinocandins for treatment of invasive fungal infections
    Michelle Turner, Richard H. Drew, John R. Perfect · 2006 · Expert Opinion on Emerging Drugs
21. In-vivo itraconazole resistance of Aspergillus fumigatus in systemic murine aspergillosis
    Éric Dannaoui, E. Borel, Florence Persat, Marie‐France Monier, M. A. Piens, Ebga Network · 1999 · Journal of Medical Microbiology
22. Comparative in Vitro Activity of Voriconazole and Itraconazole Against Fluconazole-Susceptible and Fluconazole-Resistant Clinical Isolates of Candida Species from Spain
    Manuel Cuenca‐Estrella, Teresa M. Dı́az-Guerra, Emilia Mellado, A. Monz�n, J. L. Rodr�guez-Tudela · 1999 · European Journal of Clinical Microbiology & Infectious Diseases
23. Mitogen activated protein kinases ofAspergillus fumigatus
    Gregory S. May, Tao Xue, Dimitrios P. Kontoyiannis, Michael C. Gustin · 2005 · Medical Mycology
24. Susceptibility testing of sequential isolates of Aspergillus fumigatus recovered from treated patients
    Éric Dannaoui · 2004 · Journal of Medical Microbiology
25. Isolation and in vitro susceptibility to amphotericin B, itraconazole and posaconazole of voriconazole-resistant laboratory isolates of Aspergillus fumigatus
    Elias K. Manavathu, O. C. Abraham, Pranatharthi Haran Chandrasekar · 2001 · Clinical Microbiology and Infection
26. Resistance to amphotericin B does not emerge during treatment for invasive aspergillosis
    Mohamed Y. S. Moosa · 2002 · Journal of Antimicrobial Chemotherapy
27. Antifungal Therapy of Murine Aspergillus terreus Infection
    John R. Graybill, Steve Hernandez, Rosie A. Bocanegra, Laura K. Najvar · 2004 · Antimicrobial Agents and Chemotherapy
28. Effects of cilofungin (LY121019) on carbohydrate and sterol composition ofCandida albicans
    Michael A. Pfaller, J. Riley, Theodore A.W. Koerner · 1989 · European Journal of Clinical Microbiology & Infectious Diseases
29. Aspergillus Susceptibility Testing in Patients with Cancer and Invasive Aspergillosis: Difficulties in Establishing Correlation Between In Vitro Susceptibility Data and the Outcome of Initial Amphotericin B Therapy
    Michail S. Lionakis, Russell Edward Lewis, Georgios Chamilos, Dimitrios P. Kontoyiannis · 2005 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
30. Multiple cis -Acting Sequences Mediate Upregulation of the MDR1 Efflux Pump in a Fluconazole-Resistant Clinical Candida albicans Isolate
    Davina Hiller, Stephanie Stahl, Joachim Morschhäuser · 2006 · Antimicrobial Agents and Chemotherapy
31. Differences in Interactions between Azole Drugs Related to Modifications in the 14-α Sterol Demethylase Gene ( cyp51A ) of Aspergillus fumigatus
    Guillermo García‐Effrón, Emilia Mellado, Alicia Gómez‐López, Laura Alcázar‐Fuoli, Manuel Cuenca‐Estrella, Juan L. Rodrı́guez-Tudela · 2005 · Antimicrobial Agents and Chemotherapy
32. Molecular Interactions of Cyclosporin A with P-glycoprotein
    Michel Demeule, Roland Maurice Wenger, Richard Béliveau · 1997 · Journal of Biological Chemistry
33. Anticipating Clinical Resistance to Target-Directed Agents
    Mohammad Azam, George Q. Daley · 2006 · Molecular Diagnosis & Therapy
34. Dynamic and Heterogeneous Mutations to Fluconazole Resistance in Cryptococcus neoformans
    Jianping Xu, Chiatogu Onyewu, Heather J. Yoell, Rabia Y. Ali, Rytas J. Vilgalys, Thomas G. Mitchell · 2001 · Antimicrobial Agents and Chemotherapy
35. In vitro susceptibilities of cerebrospinal fluid isolates of Cryptococcus neoformans collected during a ten‐year period against fluconazole, voriconazole and posaconazole (SCH56592)
    Ş. T. Yıldıran, Annette W. Fothergill, Deanna A. Sutton, Michael G. Rinaldi · 2002 · Mycoses
36. Caspofungin‐resistant Aspergillus flavus after heart transplantation and mechanical circulatory support: a case report
    Stephan Eschertzhuber, Corinna Velik‐Salchner, Christoph Hoermann, Daniel Hoefer, Cornelia Lass‐Flörl · 2007 · Transplant Infectious Disease
37. Detection of Aspergillus fumigatus and a Mutation That Confers Reduced Susceptibility to Itraconazole and Posaconazole by Real-Time PCR and Pyrosequencing
    Jason P. Trama, Eli Mordechai, Martin E. Adelson · 2005 · Journal of Clinical Microbiology
38. Shuttle vectors for Candida albicans: control of plasmid copy number and elevated expression of cloned genes
    Wenjin Du, Melisa Coaker, Jack D. Sobel, Robert A. Akins · 2004 · Current Genetics
39. Cloning and expression of pkaC and pkaR, the genes encoding the cAMP-dependent protein kinase of Aspergillus fumigatus
    Brian G. Oliver, John C. Panepinto, Jarrod R. Fortwendel, Darcey L. Smith, David S. Askew, Judith C. Rhodes · 2002 · Mycopathologia
40. The Ssk1p Response Regulator and Chk1p Histidine Kinase Mutants of Candida albicans Are Hypersensitive to Fluconazole and Voriconazole
    Neeraj Chauhan, Michael Kruppa, Richard Calderone · 2007 · Antimicrobial Agents and Chemotherapy
41. Multidermatomal Herpes Zoster in an AIDS Patient
    Howard E. Edelstein · 1994 · Clinical Infectious Diseases
42. Antifungal Susceptibility of Cryptococcus neoformans Isolates in HIV-Infected Patients to Fluconazole, Itraconazole and Voriconazole in Spain: 1994–1996 and 1997–2005
    Ana Isabel Aller, Rosa María Claro, C. Castro, Carmen Serrano, María Francisca Colom, Estrella Martín‐Mazuelos · 2007 · Chemotherapy
43. Erratum
    2003 · Clinical Infectious Diseases
44. Reversion of the P-glycoprotein-mediated multidrug resistance of cancer cells by FK-506 derivatives
    B Jachez, Danielle Boesch, M. A. Grassberger, Francis Loor · 1993 · Anti-Cancer Drugs
45. Sterol composition of itraconazole-resistant and itraconazole-susceptible isolates of Aspergillus fumigatus
    Éric Dannaoui, Florence Persat, E. Borel, Marie‐Antoinette Piens, Stéphane Picot · 2001 · Canadian Journal of Microbiology
46. Alexander fleming: The spectrum of penicillin
    George L. Sternbach, Joseph Varón · 1992 · Journal of Emergency Medicine
47. Clinical Efficacy and Tolerability of Caspofungin in a Renal Transplant Patient withAspergillus flavusLung Infection: Case Report
    Maria Bruna Pasticci, Francesco Barchiesi, Stefania Fallani, Nicola Palladino, Luigi Maria Lapalorcia, Marilena Gubbiotti, M. Cozzari, Andrea Novelli, F Baldelli · 2006 · Journal of Chemotherapy